A seven-year electroretinography follow-up of a patient with melanoma-associated retinopathy stabilized on pembrolizumab treatment
MAR may be the first sign of systemic metastatic melanoma, thus warranting a high degree of clinical suspicion. While OCT and ERG showed mostly concordant results over the patient's follow-up, ERG proved to be a more sensitive tool for the early diagnosis of MAR. Early immunotherapy treatment should be considered in antibody-positive MAR patients.
Authors
- Michael Ostrovsky (ORCID: https://orcid.org/0000-0001-7128-3288)
- Nancy Agmon‐Levin (ORCID: https://orcid.org/0000-0001-9514-3677)
- Ifat Sher (ORCID: https://orcid.org/0000-0003-0859-6606)
- Vicktoria Vishnevskia Dai (ORCID: https://orcid.org/0000-0001-9203-8097)
- Raz Tshuva-Bitton
Institutions
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Sheba Medical Center (IL)
- Kaplan Medical Center (IL)
Publication Details
- Journal
- American Journal of Ophthalmology Case Reports
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1016/j.ajoc.2025.102307
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.18